Brian Robison
University of Utah
10 Papers
Brian Robison is an academic researcher from University of Utah. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System
Kosj Yamoah,Myung M. Lee,Shivanshu Awasthi,Patrick R. Alba,Cristina Perez,Tori Anglin-Foote,Brian Robison,Anthony Gao,Scott L. DuVall,Evangelia Katsoulakis,Y. Wong,Sarah C. Markt,Brent S. Rose,Ryan Burri,Carrie Wang,O. Aboiralor,Angelina Fink,Nicholas G. Nickols,Julie Lynch,Isla P. Garraway +19 more
TL;DR: In this cohort study of 7.8 million patients, compared with White veterans, African American veterans displayed increased risk of developing localized and de novo metastatic prostate cancer across nationwide Veterans Affairs centers.
82
Ascertainment of Veterans With Metastatic Prostate Cancer in Electronic Health Records: Demonstrating the Case for Natural Language Processing.
Patrick R. Alba,Anthony Gao,Kyung Min Lee,Tori Anglin-Foote,Brian Robison,Evangelia Katsoulakis,Brent S. Rose,Olga Efimova,Jeffrey P. Ferraro,Olga V. Patterson,Jeremy B. Shelton,Scott L. DuVall,Julie Lynch,Julie Lynch +13 more
- 27 Sep 2021
TL;DR: For example, while localized prostate cancer has a 5-year survival rate approaching 100%, this rate drops to 31% for metastatic prostate cancer (mP... as mentioned in this paper. And prostate cancer is among the leading causes of cancer deaths.
45
Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities.
Alex K. Bryant,Myung M. Lee,Patrick R. Alba,James D. Murphy,Maria Elena Martinez,Loki Natarajan,Michael R. Green,Robert T. Dess,Tori Anglin-Foote,Brian Robison,Scott L. DuVall,Julie Lynch,Brent S. Rose +12 more
TL;DR: From 2005 to 2019, PSA screening rates decreased in the national VHA system, and facilities with higher PSA Screening rates had lower subsequent rates of metastatic prostate cancer.
25
Impact of COVID‐19 on the incidence of localized and metastatic prostate cancer among White and Black Veterans
Myung M. Lee,Alex K. Bryant,Patrick R. Alba,Tori Anglin,Brian Robison,Brent S. Rose,Julie Lynch +6 more
TL;DR: The COVID‐19 pandemic disrupted prostate‐specific antigen (PSA) screening and prostate biopsy procedures and there was a significant increase in incident mPCa cases among Black Veterans in the late pandemic period.
5
Tumor testing and treatment patterns in veterans with metastatic castration-resistant prostate cancer.
Anna Hung,Danielle Candelieri,Yanhong Li,Patrick R. Alba,Brian Robison,F. Agiri,C. Perez,Myung M. Lee,Kara N. Maxwell,Weiyan Li,Himani Aggarwal,Kathryn Pridgen,Shelby D. Reed,Scott L. DuVall,Y. Wong,Julia A. Lynch +15 more
TL;DR: In this article , the use of tumor testing and treatment patterns in Veterans who progressed to metastatic castration-resistant prostate cancer (mCRPC) from 2016 to 2021 were described.
3